https://oncbrain.oncologytoolkit.com/ AI-summarized oncology meeting studies, curated by a subspecialist. One item per study. en Sun, 31 May 2026 00:00:00 GMT https://oncbrain.oncologytoolkit.com/2026-05-31/#miracle-2 https://oncbrain.oncologytoolkit.com/2026-05-31/#miracle-2 Sun, 31 May 2026 00:00:00 GMT lower-gi [Early signal] 68% ORR, median OS 23.2mo, 18% NED in MSS unresectable metastatic rectal ca (N=50). Eligible: MSS unresectable metastatic rectal cancer, synchronous mets, first-line